Viatris Closes Acquisitions Of Oyster Point Pharma And Famy Life Sciences, Establishing New Viatris Eye Care Division
Acquiring Company
Viatris
Acquired Company
Famy Life Sciences
Description
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris' strategic update. Former Oyster Point Pharma CEO, Jeffrey Nau, Ph.D., MMS, will lead the new division.
Quick answer
Viatris is acquiring Famy Life Sciences and Oyster Point Pharma, Inc., announced January 3, 2023. Viatris is based in Canonsburg, Pennsylvania, United States.
- How much did Viatris pay for Famy Life Sciences?
- The deal value was not disclosed.
- What does Viatris do?
- Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania.
- Where are Viatris and Famy Life Sciences based?
- Viatris is based in Canonsburg, Pennsylvania, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck Completes Tender Offer To Acquire Imago Biosciences, Inc. (January 11, 2023)
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
- Cvs Health To Acquire Oak Street Health (February 8, 2023)
- Sherlock Biosciences Acquires Sense Biodetection Advancing Crispr-Based Diagnostics For Consumers (February 1, 2023)
- Tivity Health Acquires Industry Leading Digital Health And Wellness Platform Burnalong (January 31, 2023)
- Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S. (January 25, 2023)
Who to call at Viatris, and when
When Viatris changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Viatris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viatris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viatris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viatris makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Famy Life Sciences?
Famy Life Sciences was acquired by Viatris, based in Canonsburg. The deal was reported on January 3, 2023. Viatris is a global healthcare and pharmaceutical corporation based in Canonsburg, Pennsylvania. Viatris is publicly traded (VTRS).
When did Viatris acquire Famy Life Sciences?
Viatris's acquisition of Famy Life Sciences was reported on January 3, 2023. Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Famy Life Sciences do?
Famy Life Sciences is a well-known drug development platform specializing in identifying and in-licensing best-in-class clinical-stage assets. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.